Anika Therapeutics (ANIK) Competitors $11.26 +0.02 (+0.13%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. CERS, OSUR, UTMD, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Anika Therapeutics vs. Its Competitors Cerus OraSure Technologies Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Anika Therapeutics (NASDAQ:ANIK) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends. Which has more volatility and risk, ANIK or CERS? Anika Therapeutics has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Does the media refer more to ANIK or CERS? In the previous week, Cerus had 2 more articles in the media than Anika Therapeutics. MarketBeat recorded 3 mentions for Cerus and 1 mentions for Anika Therapeutics. Cerus' average media sentiment score of 1.49 beat Anika Therapeutics' score of 0.00 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cerus 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ANIK or CERS more profitable? Cerus has a net margin of -10.23% compared to Anika Therapeutics' net margin of -41.28%. Anika Therapeutics' return on equity of -7.22% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Anika Therapeutics-41.28% -7.22% -5.64% Cerus -10.23%-34.81%-9.68% Which has stronger earnings & valuation, ANIK or CERS? Cerus has higher revenue and earnings than Anika Therapeutics. Cerus is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnika Therapeutics$119.91M1.35-$56.38M-$3.88-2.90Cerus$185.14M1.55-$20.92M-$0.10-15.00 Do analysts recommend ANIK or CERS? Anika Therapeutics presently has a consensus target price of $20.00, suggesting a potential upside of 77.54%. Cerus has a consensus target price of $3.50, suggesting a potential upside of 133.33%. Given Cerus' higher possible upside, analysts plainly believe Cerus is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders have more ownership in ANIK or CERS? 91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 9.6% of Anika Therapeutics shares are held by insiders. Comparatively, 5.6% of Cerus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryCerus beats Anika Therapeutics on 10 of the 17 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANIK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$161.54M$2.88B$5.49B$9.01BDividend YieldN/A2.43%5.38%4.09%P/E Ratio-2.9021.5627.4520.27Price / Sales1.35244.24407.33121.26Price / Cash117.9441.9536.6357.47Price / Book1.077.518.095.67Net Income-$56.38M-$55.05M$3.17B$248.63M7 Day Performance4.89%4.61%2.82%3.30%1 Month Performance-3.30%4.89%3.70%5.20%1 Year Performance-55.58%5.84%35.42%21.36% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics3.7794 of 5 stars$11.27+0.1%$20.00+77.5%-55.6%$161.54M$119.91M-2.90300CERSCerus3.43 of 5 stars$1.34flat$3.50+161.2%-12.8%$256.15M$180.27M-13.40290News CoveragePositive NewsOSUROraSure Technologies1.0444 of 5 stars$3.03+1.0%$3.00-1.0%-23.6%$226.64M$161.63M-7.21840UTMDUtah Medical Products2.4093 of 5 stars$54.89+2.3%N/A-12.2%$178.28M$39.27M14.52180News CoveragePositive NewsWSTWest Pharmaceutical Services4.7653 of 5 stars$217.05+0.6%$332.50+53.2%-31.0%$15.60B$2.89B34.0710,600COOCooper Companies3.4478 of 5 stars$69.52+0.1%$99.70+43.4%-14.6%$13.90B$3.90B33.7516,000High Trading VolumeALGNAlign Technology4.5479 of 5 stars$183.42+0.9%$241.25+31.5%-19.1%$13.30B$4.00B33.4120,945Positive NewsMMSIMerit Medical Systems4.377 of 5 stars$92.32+0.4%$109.11+18.2%+9.0%$5.46B$1.36B45.267,400News CoveragePositive NewsHAEHaemonetics4.8613 of 5 stars$72.15+1.5%$97.89+35.7%-8.7%$3.47B$1.36B21.803,023ICUIICU Medical4.5322 of 5 stars$128.07+0.3%$192.67+50.4%+14.8%$3.15B$2.38B-33.4415,000XRAYDENTSPLY SIRONA4.5043 of 5 stars$15.48+0.8%$20.36+31.5%-33.2%$3.09B$3.79B-3.4114,000Positive News Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANIK Stock Alerts